Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Precision Medicine and Therapeutic Resistance
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Discovery
Cancer Discovery
  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Precision Medicine and Therapeutic Resistance
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

Research Watch

The Spindle Assembly Checkpoint Is a Vulnerability of Aneuploid Cells

DOI: 10.1158/2159-8290.CD-RW2021-017 Published March 2021
  • Article
  • Info & Metrics
  • PDF
Loading
  • Major Finding: Cancer cells with abnormal chromosome numbers were sensitive to spindle assembly checkpoint inhibition.

  • Concept: KIF18A, encoding a kinesin superfamily molecular motor, was a key dependency in these cells.

  • Impact: This work identifies a target in cells that exhibit aneuploidy, which is a common feature of cancer.


Embedded Image

Abnormal chromosome number, including both aneuploidy and whole-genome doubling (WGD), is a common feature of cancer cells that is normally absent in nonmalignant cells, but whether these genetic aberrations are therapeutically targetable has not been established. Complementary work by Quinton and colleagues along with Cohen-Sharir and colleagues revealed that the spindle assembly checkpoint was a vulnerability of cancer cells with an abnormal number of chromosomes. To approach the question, Quinton and colleagues analyzed sequencing data from approximately 10,000 primary human cancer samples and genetic essentiality data from about 600 cell lines, whereas Cohen-Sharir and colleagues investigated aneuploidy in roughly 1,000 human cancer cell lines, leveraging genetic and chemical perturbation screens to pinpoint vulnerabilities. Counterintuitively, Cohen-Sharir and colleagues found that aneuploid cancer cells were less susceptible than diploid cells to brief pharmacologic inhibition of the spindle assembly checkpoint using a variety of inhibitors; rather than halting cell division upon this inhibition, the aneuploid cells adopted alternate spindle geometry and dynamics. This caused mitotic defects, exacerbating the already abnormal karyotypes of the aneuploid cancer cells and leading to increased sensitivity to inhibition of the spindle assembly checkpoint over time. Additionally, both groups pinpointed KIF18A, encoding a microtubule-associated molecular motor in the kinesin superfamily that is involved in the spindle assembly checkpoint, as a key dependency of aneuploid cancer cells. Specifically, Quinton and colleagues determined that KIF18A loss was tolerated by diploid cells but led to mitotic defects and reduced viability in cells that had undergone WGD. Further, Cohen-Sharir and colleagues found that KIF18A overexpression sensitized aneuploid cancer cells to inhibition of the spindle assembly checkpoint. Together, the work of these two groups establishes the spindle assembly checkpoint and KIF18A as specific vulnerabilities of cancer cells with chromosome copy-number aberrations, providing insight into a process that may be targetable.

Cohen-Sharir Y, McFarland JM, Abdusamad M, Marquis C, Bernhard SV, Kazachkova M, et al. Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition. Nature 2021 Jan 27 [Epub ahead of print].

Quinton RJ, DiDomizio A, Vittoria MA, Kotýnková K, Ticas CJ, Patel S, et al. Whole-genome doubling confers unique genetic vulnerabilities on tumour cells. Nature 2021 Jan 27 [Epub ahead of print].

Notes

Note: Research Watch is written by Cancer Discovery editorial staff. Readers are encouraged to consult the original articles for full details. For more Research Watch, visit Cancer Discovery online at http://cancerdiscovery.aacrjournals.org/CDNews.

  • ©2021 American Association for Cancer Research.
PreviousNext
Back to top
Cancer Discovery: 11 (3)
March 2021
Volume 11, Issue 3
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Spindle Assembly Checkpoint Is a Vulnerability of Aneuploid Cells
(Your Name) has forwarded a page to you from Cancer Discovery
(Your Name) thought you would be interested in this article in Cancer Discovery.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Spindle Assembly Checkpoint Is a Vulnerability of Aneuploid Cells
Cancer Discov March 1 2021 (11) (3) 533; DOI: 10.1158/2159-8290.CD-RW2021-017

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Spindle Assembly Checkpoint Is a Vulnerability of Aneuploid Cells
Cancer Discov March 1 2021 (11) (3) 533; DOI: 10.1158/2159-8290.CD-RW2021-017
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Notes
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Research Watch

  • Cell-Intrinsic Programs Partition Nutrients in Tumor Microenvironment
  • Extrachromosomal DNA Can Promote Oncogene Transcription in Trans
  • Transient Rest Reverses Exhaustion of Chimeric Antigen Receptor T Cells
Show more Research Watch

Genetics

  • Noncanonical Open Reading Frames Produce Functional Proteins in Cancer
  • Chromothripsis Generates Oncogene-Containing Extrachromosomal DNA
Show more Genetics
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement